Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington Disease
Condition: Huntington Disease Intervention: Genetic: intra-striatal rAAV5-miHTT Sponsor: UniQure Biopharma B.V. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials